Fierce Life Sciences Events
Rui Yang, Ph.D. MBA, serves as Marketing Director for Radioligand Therapy at Novartis, overseeing metastatic indication brand strategy and execution, as well as leading marketing strategies for breast cancer. Concurrently, Rui holds positions as Adjunct Professor of Marketing at NYU Stern School of Business, teaching healthcare marketing, and as Advisory Board Member for both Harvard Business Review and Fierce Life Sciences Events. Prior experience includes significant roles at Reckitt, Edgewell Personal Care, and Bayer Pharmaceuticals, focusing on brand strategy, innovation, and P&L management. Rui earned an MBA from NYU Stern and a Ph.D. in Chemistry from Stony Brook University, complemented by a B.S. from Shandong University.
This person is not in any teams
Fierce Life Sciences Events
The Fierce Life Sciences team develops engaging, content- driven conferences which attract decision makers across the pharmaceutical and healthcare community. Our conference producers work in collaboration with our editorial teams and industry advisory boards to put together compelling event programs. With over 40 annual events, we are the proud organizers of Digital Pharma East, the TMF Summit, the Clinical Quality Oversight Forum, the Fierce JPM Morgan breakfast, the Fierce Biotech Forum and many more. Our virtual and live events facilitate the exchange of critical information between industry professionals and are based on extensive market research and targeted outreach to speakers and panelists. Our events provide important topical information and networking opportunities with a clear delineation between content and commercialism.